Background: UK Hospital Trusts are charged with increasing patients' research aware-
| INTRODUCTION
Since the 1990s, a greater role of patients in clinical research in the United Kingdom (UK) has been advocated, with patients positioned as "consumers" and "service users," rather than as "research subjects." 1, 2 At the same time, the UK's National Institute of Health Research (NIHR) has sought to encourage greater participation of patients in clinical research conducted in the National Health Service (NHS). Long-standing concerns about shortcomings in participant recruitment to clinical trials and other types of health research have been widely reported. A Cochrane review that included 45 trials, reported that "it is likely that less than 50% [of clinical studies] meet their target [in patient recruitment], or meet their target without extending the length of the trial." 3 The authors suggest that recruitment may be viewed as problematic by clinical research stakeholders, outlining three main concerns: At the scientific level, "underpowered" studies may report as statistically non-significant results which are nonetheless clinically relevant; ethically, participants in "underpowered" studies have been exposed to interventions with uncertain benefit but the effectiveness of the intervention remains uncertain; and on economic grounds, they underline that greater costs may be incurred if "underpowered" studies need to be extended to arrive at statistically significant results. These three concerns provide a framework within which to understand why stakeholders consider greater numbers of participants as vital to the efficiency and efficacy of clinical research .
Patient recruitment into clinical research is subject to three core considerations: approach (how to reach sufficient numbers of participants), eligibility and retention. To increase recruitment, the NIHR has proposed that UK health organizations develop a "research culture," focused on delivering innovation in research and care provision, 4 which encourages patients to proactively seek involvement in clinical research. The clinical research network aims to support the development of such a "research culture" by "providing NHS Trusts with additional funding to cover the cost of research nurses and other clinical research delivery staff, who identify and approach patients about relevant research opportunities." 5 Not only does this work aim at recruiting patients, but even more so at encouraging patients to voluntarily and of their own accord come forward to enquire about, and subsequently participate in clinical research. frames research participation as both a right and an obligation, a way to "give back" to the health-care system to help improve care whilst benefitting on various levels including generating a sense of community, becoming more informed about illness, gaining access to latest treatments and gaining a feeling of more control over their illness.
The messages of "I am Research" dually frame patient participation in terms of reciprocity for health-care provision based on equity or solidarity whilst calling upon the imagined patient's more economic reasoning of cost-benefit. 
| CASE STUDY

| METHODS
Pre
| Delivery of the questionnaire
Research assistants conducted the survey face-to-face, recording participants' responses via the website https://www.surveymonkey.
com/ on a hand-held tablet device. All new patients to the outpatient clinic, identified by clinic staff, asked to participate in this evaluation.
Participants were approached immediately after their medical appointment to provide an opportunity for them to have asked about taking part in clinical research should they so wish.
The pre-intervention survey was administered at seven clinics be- 3 minutes to administer, the post-intervention survey around 5 minutes.
Both were deliberately short to encourage a high response rate. No identifying patient data were collected. Ethics committee approval was not required as the survey was NHS pre-assessed to fall within the category of "service evaluation" (http://www.hra.nhs.uk/research-community/ before-you-apply/determine-whether-your-study-is-research/).
| Data analysis
Survey responses were tabulated and analysed for frequencies. Openended comments were recorded verbatim and coded to facilitate grouping into broader categories. At this stage, findings were presented to two local patient and public involvement groups, with discussion on interpretation of the results and their implications.
| Survey results
In total, 453 patients were approached to take part in the two sur- 
| Impact of the research statement
This section focuses on results from the survey designed to assess the impact of the statement (post-intervention). 
| Notice
Only 15% of participants indicated that they noticed the letter statement; 85% said they did not. In the Open Comments section of the survey, patients suggested that they did not notice the statement because they had used the letter to primarily learn about the time and date of their appointment, or because they had lost the letter or disposed of it once they had noted the details for their appointment.
| Clarity
When participants read the statement, the majority (56%) found its content "a little unclear", whilst 7% perceived it to be "very unclear". A third (33%) of patients felt that the statement was "clear," and only a minority of 4% found it "very clear". In their Open Comments, two patients expressed difficulty understanding the statement, suggesting, respectively, that it was "too wordy" and "too long". 
| Helpfulness
The statement was considered to be of "little help" for encouraging research participation by 76% of participants, only a minority found it helpful. Some participants reported through the Open Comments that they had noticed the statement and were interested in taking part, but had not asked about research because they forgot to ask, or they were concerned they would "waste" time in their clinical appointment, which they felt was already short.
The pre-intervention survey provides baseline data on the propensity of patients in this clinic to ask about taking part in research.
Thirteen per cent (n = 26, of 207) reported that they had asked about taking part in research. However, this response includes the enquiries patients made about research to any health-care professional, including those outside the Trust, and is not limited to enquiries made during patients' first appointments at the Trust.
Patients participating in both surveys were asked if, since their diagnosis, anyone had discussed with them whether they would like to take part in research. Of the 321 patients (70% of the overall sample of approached patients in both surveys) who had never been approached to take part in clinical research, 43% responded that they would not like to have been asked. Meanwhile, 24% said they would like to have been asked, and 33% said they did not know whether or not they would have like to have been asked. These findings suggest that the health- Not helpful at all 13 of their illness did not merit participation in research (not sufficiently serious) or their diagnosis and treatment pathway were clear; and some participants considered a clinical appointment an inappropriate occasion to discuss research as they perceived there would be a conflict of interest if their clinician were to discuss research participation with them. Nevertheless, there is a considerable constituency of patients that would be ready to engage in discussions about research even if they were not inspired by the research statement to initiate an enquiry.
The finding that only one patient of 195 asked about taking part in research after reading the research statement suggests that, in this pilot intervention, a research statement inserted into an outpatient letter did not have a large immediate effect on patient-initiated recruitment.
| Limitations of the evaluation
It is important to note the limitations of the evaluation. 
| DISCUSSION
This evaluation found that a small proportion of patients (13%) had previously enquired about research participation, although we do not know where or when this enquiry had been made. We also found the research statement had limited success encouraging patients to ask about participating in clinical research (1 of 195 participants). There are several possible reasons for this: the "visibility" of the statement, being of black text at the foot of the letter; the possibility that patients were primarily concerned about the information related to their first specialist appointment; or their prioritizing getting a confirmed diagnosis from a hospital specialist. A large majority (70%) reported never being asked to take part in research; of these, 43% would not like to have been asked and 33% did not know whether or not they would have liked to have been asked. These results should be compared with other studies investigating patients' willingness to be informed about and participate in research, where reported estimates vary, depending on setting and population. In a 2000 study of a random population sample in the United States, 46% reported being willing to take part research on new treatments for a disease that was of concern to them, with 29% undecided. 8 A Korean survey found that 25% of randomly selected members of the public would be willing to participate in a future trial, 9 with the same proportion reported from a German study of the general public. 10 Patient populations report higher levels of willingness to participate. In a 2006 survey of 400 outpatients at a general internal medicine practice at a tertiary care academic medical centre in the United States, 68% showed "interest" in participating in clinical trials. 11 The UK National Cancer Experience Survey reported that 95% of patients who had research discussed with them were happy to have been asked and 53% of those with whom research was not discussed would have been happy to have been asked. 7 Moorcraft et al 12 report that most patients in a specialist cancer hospital were happy to be approached about research participation, and 88 % of those approached during the study period consented to take part in a clinical trial. 12 However, they note that "patients who have just started their first treatment for cancer are less likely to participate in cancer research and it appears that as time increases from diagnosis, patients are more positive about engaging with research" (2016:8).
The Cochrane review by Treweek and colleagues, 3 cited in the Introduction to this paper, seeks to quantify the effects of strategies to improve recruitment of participants to randomized controlled trials.
They report that promising approaches include telephone reminders;
requiring potential participants to opt-out of being contacted by the trial team regarding taking part in a trial, rather than them having to opt-in; and open designs. These recruitment strategies presuppose prior identification and access to patients who represent eligible potential trial participants and require considerable time investment by the trial team who will also be busy fulfilling other roles in the research process. As such, it is likely that such strategies can only meaningfully increase patient participation with groups that are easy to access by trial teams. Recent and ongoing efforts by the NIHR (eg, the two campaigns and the research statement in patient admission letters), however, aim to reduce the effort necessary to recruit by shifting work to patients themselves, and to broaden the constituency of patients participating in trials. The research statement may have been deployed expecting patients to have been engaged already by the "OK to Ask" campaign, which aims to make the idea of clinical research accessible to patients, and to emphasize those aspects reported as enablers in the literature. There is little evidence of the effectiveness of this campaign but the results of this evaluation suggest that the research statement of itself is not effective, at least for new clinic attenders.
The exploration of diverse barriers and enablers to public participation in clinical research has become a vital resource for understanding existing recruitment limitations and provides a basis for developing proposals on how to address these. 13 This literature shows that patients have very diverse and also multiple reasons for either participating or not participating in research. [14] [15] [16] [17] A closely related body of scholarship explores the under-representation of certain groups of patients in research, reflecting underlying concerns about equity and equality, and about the impact of under-representation of specific groups on the validity of the research. Recurring categories here include (but not limited to) ethnicity, 18 language skills, 19 age, 20 socio-economic status, 21 educational levels 22 and awareness of research and research literacy.
23,24
| 499
This body of work shows that potential trial participants come from very diverse constituencies and that there are both structural (social and research institutional) as well as personal barriers to participation.
These efforts, at least in part, can provide the means to compensate for an increasing methodological formalism in recruiting patients which threatens to substitute substantive concern with the reasons why certain populations may be hard to recruit into clinical research. 25 and an addresser. The research statement in the letter aims to address not just any public but an "active," "attentive" public who understands the context and rationale for the statement to be able to act upon it and has an interest in doing so. To be attentive, the patient audience needs to "have a special incentive for assessing the common content of issues, for they have a particular stake in issues… have greater knowledge about the issue domain and should be more aware of the implications of issues." 31 This cannot be presupposed for as diverse a public as health-care service users, especially not when taking into consideration the empirical findings of research on barriers to research and participation, and on under-represented groups, each of which have a variety of characteristics defining specific constituencies and helping to understand their limitations in accessing research. The statement in the letter does not address each constituency in terms capable of overcoming such limitations.
The findings from this case study lead us to suggest that perhaps the UK health-care system-particularly the relationship between care
provision and clinical research-remains black-boxed to a large part of the patient population and does not reproduce the attentive audience imagined by the NIHR and its institutional executors as potential research participants. To be able to reach as many different patients as possible and to "activate" these towards patient-initiated recruitment, the broad concept of patient may need to be disaggregated so that specific audiences can be addressed.
| CONCLUSION
Our results suggest that simple, single-solution approaches to increasing research awareness-such as including research statements in out- Therefore, there is an ongoing need to develop the health-care system's approach to patients: patients are not one homogenous public, but are diverse publics that need to be addressed as specific audiences along a broad continuum of different priorities and needs, values and perceptions.
